0001600132-17-000102.txt : 20170926
0001600132-17-000102.hdr.sgml : 20170926
20170926165912
ACCESSION NUMBER: 0001600132-17-000102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170922
FILED AS OF DATE: 20170926
DATE AS OF CHANGE: 20170926
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tasse Daniel
CENTRAL INDEX KEY: 0001502785
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 171102611
MAIL ADDRESS:
STREET 1: C/O IKARIA, INC.
STREET 2: 6 STATE ROUTE 173
CITY: CLINTON
STATE: NJ
ZIP: 08809
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
4
1
wf-form4_150645953894625.xml
FORM 4
X0306
4
2017-09-22
0
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001502785
Tasse Daniel
C/O BELLEROPHON THERAPEUTICS, INC.
184 LIBERTY CORNER ROAD, SUITE 302
WARREN
NJ
07059
1
0
0
0
Stock Option (right to buy)
1.12
2017-09-22
4
A
0
10000
0
A
2027-09-21
Common Stock
10000.0
10000
D
This option was granted on September 22, 2017. This option vests in three equal annual installments over a three-year period from the date of grant.
/s/ Daniel Tasse
2017-09-26